Purchase Order 36C24823P0565
Award Date
1/30/23
Potential Completion Date
1/17/24
Potential Value
$202K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33125, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for germline genetic testing services. The contract has a ceiling value of $95,817.89 and a period of performance through September 30, 2018. It was awarded as a total small business set-aside. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits and services to various federal agencies, including the VA,...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a provider of genomic testing services and COVID-19 testing kits and services to U.S. federal government agencies. The contract is for germline genetic testing with a potential value of $150,000.00 and is a Firm Fixed Price BPA Call order. Fulgent Therapeutics holds a separate $950,000.00 Blanket Purchase Agreement from...
This is a firm fixed price definitive contract awarded by the Veterans Integrated Service Network 17 of the Department of Veterans Affairs to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for $1,010,000.00 and has a period of performance through September 30, 2028. The contract is for genetics testing services, including clinical genetic testing, germline genetic testing utilizing whole genome sequencing, custom gene...
The Department of Veterans Affairs Veterans Health Administration awarded Fulgent Therapeutics LLC a $3.2 million firm fixed price delivery order against its Medical Laboratory Testing and Analysis Services GSA Schedule contract. Fulgent Therapeutics, doing business as Fulgent Diagnostics and a division of Fulgent Genetics, will provide COVID-19 cost per test services to VHA's Veterans Integrated Service Network 21 through December 2020. The contract supports VHA's coronavirus disease testing...
This is a $6,489,759.80 firm fixed price Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc., for germline genetic testing services. The contract has a 3-year term through September 2025 and is not set-aside. The contract will provide national access to specialized comprehensive reference laboratory testing services, including mandatory...
This is a federal contract award from the Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The $2,300,000 firm fixed-price delivery order is for germline pharmacogenomic molecular testing services, with a period of performance through September 30, 2025. The contract is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the VA Strategic...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for the delivery of laboratory testing kits, with a ceiling value of $889,097.43 and a period of performance through December 30, 2024. There was no set-aside designation used for this award. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $104,500 firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for the procurement of next generation DNA sequencing services. Fulgent Therapeutics is a subsidiary of Fulgent Genetics, Inc. and has previously provided genetic and genomic testing services to various federal agencies, including the...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order valued at $7,251 to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a division of Fulgent Genetics, Inc. The contract is for anatomic pathology laboratory services to be performed at the Southern Arizona VA Healthcare System in Tucson, Arizona, over a one-year base period ending August 31, 2023. Services include pathology consultations, immunohistochemical staining,...
This federal contract award was issued by the Veterans Integrated Service Network 6 (VISN 6), a division of the U.S. Department of Veterans Affairs (VA), to Prevention Genetics LLC, a for-profit limited liability company that provides genetic testing services. The $55,800 firm-fixed-price purchase order is for the provision of genetic testing panels, excluding exome testing, with a period of performance through March 21, 2024. The original solicitation was issued by the Richmond VA Medical...